In den Warenkorb
Bestellen Sie auch über:
![]() |
+33 (0)1 76 63 32 65 |
![]() |
+33 (0)1 74 18 08 22 |
Amyloid beta (Abeta) (N-Term) Antikörper
| Antigen | Amyloid beta (Abeta) |
| Synonyme | AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, CTFgamma, aaa, ad1, pn2, abpp, appi, cvap, abeta, MGC88882, ctfgamma, APP |
| Epitope |
Alternativen N-Term |
| Klonalität | Polyklonal |
| Wirt |
Alternativen Kaninchen |
| Reaktivität |
Alternativen Human |
| Applikation |
Alternativen Immunhistochemie (IHC), Western Blot (WB)
|
| Produktnummer | ABIN180178 |
| Menge | 100 µg |
| Preis | 324,00 € Zzgl. Versandkosten €40,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 10 bis 15 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | Amyloid b (N terminal) |
| Immunogen | Synthetic peptide for N-terminal of Human AmyloidÀ |
| Isotyp | IgG (Passende Sekundärantikörper) |
| Beschreibung | Alzheimer's Disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles(NFTs) in the brain. The major protein component of these plaques is beta amyloid peptide (AÀ ), a 40 to 43 amino acid peptide cleaved from amyloid precursor protein by À -secretase and a putative Á secretase. Increased release of the `longer forms' of AÀ peptide, AÀ 42 or A À 43, which have a greater tendency to aggregate than A À 40, occurs in individuals expressing certain genetic mutations, expressing certain ApoE alles, or may involve other, still undiscovered, factors, Many researchers theorize that it is this increased release of AÀ 42/A À 43 which leads to the abnormal deposition of A À and the associated neurotoxicity in the brains of affected individuals. |
| Spezifität | React with all of Human AmyloidÀ [1-40], [1-42] and [1-43] |
Anwendungen
| Applikationshinweise | This antibody can be stained in formalin fixed paraffin embedded tissues after formic acid treatment*1 by several Immunohistochemical techniques such as Avidin Biotin Complex (ABC) Method. The optimal dilution is 1·` 5 ug/ml, however, the dilution rate should be optimized by each laboratories. This antibody can be used for Western blotting in concentration of 5 ug /ml. *1 Rinsing by running water after formic acid treatment for 5 minutes following de-paraffin. |
| Reinigung | Antigen peptide |
| Buffer | Lyophilized product from 1% BSA in PBS containing 0.05%NaN3 . Reconstitution: 0.5 ml distilled water will be added to the product |
| Lagerung | Lyophilized product, 5 years at 2 8 C : Solution, 2 years at 20 C |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Bilder
| anti-Amyloid beta (Abeta) (N-Term) antibody anti-Amyloid beta (Abeta) (N-Term) antibody (Image 2) |
Alternativen
Alternativen zu Antigen "Amyloid beta (Abeta)", Typ "Antikörper" finden




Alternativen